Project Timeline and News

CCS Breakthrough Team Grant Received

1000^th patient enrolled at UHN

1^st patient recruited in Nova Scotia

1^st patient with Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) recruited into CHARM

1^st patient recruited in Newfoundland and Labrador

1^st Birt-Hogg-Dubé Syndrome patient enrolled into CHARM

1^st Multiple Endocrine Neoplasia patient enrolled into CHARM

1000^th patient recruited into CHARM

1^st Hereditary Paraganglioma-Pheochromocytoma Syndrome patient enrolled into CHARM

1^st Von Hippel-Lindau disease patient recruited into CHARM

1st patient recruited in Quebec

100^th patient recruited at Mount Sinai Hospital

1^st patient recruited at BC Cancer 

200^th Neurofibromatosis type 1 patient recruited into CHARM

1^st child with Neurofibromatosis type 1 recruited at SickKids

75^th Li-Fraumeni syndrome patient recruited into CHARM

500^th patient recruited into CHARM

TD Ready Challenge Grant awarded

1^st patient recruited at Mount Sinai Hospital

Recruitment of individuals with hereditary cancer syndromes began at Mount Sinai in September 2019, following the 8^th annual Lynch Syndrome Education Night.

Qualitative findings from CHARM presented at 2019 ARCC

Leslie Oldfield, Project Manager at the Pugh Lab, presented qualitative findings in support of Aim 3 of the CHARM study (to optimize integration of ctDNA into clinical practice). These findings were presented at the 8^th annual Canadian Centre for Applied Research in Cancer Control (ARCC) Conference in Halifax, Nova Scotia.

Children’s Tumor Foundation Clinical Research Award granted

The Children’s Tumor Foundation’s mission is to drive research, expand knowledge, and advance care for the NF community. Their Clinical Research Award was granted to CHARM in order to develop cell-free DNA detection technologies in application to NF1. The tests and technologies used by CHARM will improve cancer care and health outcomes for those living with NF1.

Initial CIHR grant received

1^st patient recruited at University Health Network

Our team of Clinical Research Coordinators recruited the first patients with hereditary cancer syndromes into the CHARM study during July of 2018, starting with Princess Margaret Cancer Centre and the rest of University Health Network.